In T2D mice, irisin prevents bone loss by attenuating inflammasome-associated pyroptosis signaling via the miR-150-FNDC5/Irisin/pyroptosis axis, making it a promising therapeutic target for osteoporosis associated with diabetes (111). This evidence concerns the gene FNDC5 and diabetes mellitus.